[Catheter ablation in supraventricular tachycardia]

Area of Science:

• Electrophysiology
• Cardiovascular Medicine
• Interventional Cardiology

Context:

• Radiofrequency (RF) catheter ablation has evolved significantly since its inception in 1986, driven by advancements in catheter technology and generator systems.
• Electrophysiologists have deepened their understanding of arrhythmogenic substrates, including accessory pathways, AV nodal pathways, and atrial flutter mechanisms.
• Mapping techniques like transient and concealed entrainment are crucial for precise RF catheter ablation localization.

Purpose:

• To establish catheter ablation as a first-choice curative treatment for supraventricular tachycardias (SVT).
• To detail the efficacy and success rates of RF catheter ablation for various SVT types, including AV nodal reentrant tachycardia (AVNRT) and accessory pathway-mediated reentrant tachycardia.
• To discuss the experimental status and challenges of catheter ablation for atrial fibrillation.

Summary:

• RF catheter ablation is the primary treatment for SVTs, affecting approximately 5 per mill of the population (excluding atrial fibrillation).
• High success rates (>93% for AVNRT and accessory pathways, 80% for atrial flutter) have been achieved in treating various tachyarrhythmias.
• While effective for many SVTs, atrial fibrillation ablation remains experimental due to complex pathophysiology and mapping challenges.

Impact:

• Catheter ablation is now the preferred curative treatment for a significant portion of patients with supraventricular tachycardias.
• The procedure offers high success rates and improved patient outcomes compared to medical therapy for specific arrhythmias.
• Further research into atrial fibrillation ablation holds potential for treating a broader range of cardiac arrhythmias.